SBRA Sabra Healthcare REIT Inc

Voya Investment Management LLC has increased its stake in Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) by 29.8% to 666,364 shares, valued at approximately $12.42 million. Sabra Healthcare REIT pays a quarterly dividend of $0.30, resulting in an annualized yield of about 6.5%, though its dividend payout ratio is high at 166.7%. Analyst sentiment for SBRA is mixed-to-positive, with an average rating of "Moderate Buy" and a price target of $21.00.

Sabra Health Care REIT (SBRA) is presented as a compelling dividend value investment with a 6.4% yield and strong fundamentals, including an investment-grade rating and no debt maturities until 2027. The company's SHOP segment is driving growth, with a focus on increasing its NOI mix and benefiting from demographic tailwinds and limited new supply. This positions SBRA for potential annual total returns of 11-12%.

Sound Income Strategies LLC significantly increased its stake in Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) by 42,486.2% in Q3, purchasing 719,716 additional shares to hold 721,410 shares valued at approximately $12.9 million. Sabra Healthcare REIT recently posted Q3 EPS that slightly beat expectations and announced a quarterly dividend of $0.30, representing an annualized yield of 6.4%. Analyst consensus for SBRA is a "Moderate Buy" with a target price of $21.00.

Engineers Gate Manager LP significantly increased its stake in Sabra Healthcare REIT (SBRA) by 3,190.3% in Q2, making it their 5th largest position. Sabra Healthcare REIT recently paid a $0.30 quarterly dividend, offering a 6.3% yield, and analysts maintain a "Moderate Buy" consensus with a target price of $20.88. The company's stock is currently trading near $19, and its Q3 earnings topped estimates with revenue up 6.7% year-over-year.

Quantbot Technologies LP has acquired 66,745 shares of Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) for approximately $1,231,000 during the second quarter. Other institutional investors have also adjusted their holdings in the company, which has an average analyst rating of "Moderate Buy" and an average target price of $20.88. Sabra Healthcare REIT recently announced a quarterly dividend of $0.30 per share.

Hsbc Holdings PLC significantly reduced its stake in Sabra Healthcare REIT, selling 190,367 shares and ending Q2 with approximately 0.09% of the company valued at $3.93 million. Despite this, Sabra Healthcare REIT reported a quarterly dividend of $0.30 and slightly beat EPS expectations with $0.38, while analysts anticipate 1.45 EPS for the current year. The company maintains a market capitalization of ~$4.81 billion and an average rating of "Moderate Buy" from analysts with a price target of $20.88.